Belatacept Post Depletional Repopulation to Facilitate Tolerance
Clinical trial NCT00565773 · COMPLETED
Trial details
- NCT number
- NCT00565773
- Sponsor
- Allan D Kirk, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2017-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.